文献速递复苏、休克与脓毒症消化、代谢与肾脏急症

急诊科实施单核细胞分布宽度(MDW)检测对脓毒症患者抗感染给药时间的影响:前后队列研究

Clinical impact of the implementation of monocyte distribution width (MDW) measurement on time to anti-infective administration in sepsis patients in the emergency department: a before/after cohort study.
PubMed 文献 · Crit Care · 2024-10-27
一句话结论急诊实施床旁MDW检测未显著缩短从到院至抗感染给药时间,但显著缩短了从脓毒症发病至给药时间(3.7 h vs 2.2 h,p<0.001)。

在巴黎一家学术医院急诊科开展前后队列研究,比较实施床旁MDW检测前后脓毒症患者的救治与结局。实施期护士随全血细胞计数测MDW、2分钟出结果,MDW>21.5单位时要求急诊医师考虑脓毒症并尽快启动抗感染。共纳入实施前255例、实施后180例脓毒症患者;从到院至抗感染给药时间5.4 h vs 4.9 h(p=0.06),从脓毒症发病至给药时间由3.7 h降至2.2 h(p<0.001),死亡率18% vs 16%(p=0.4)、住院率93% vs 91%(p=0.4)、急诊停留时间7.2 h vs 7.0 h(p=0.7)均无显著差异。作者认为急诊流程中实施床旁MDW检测可提高从脓毒症发病起抗感染给药的及时性,符合当前脓毒症管理指南。

要点

  • 实施期护士随全血细胞计数测MDW、2分钟出结果;MDW>21.5单位时要求急诊医师考虑脓毒症并尽快启动抗感染。
  • 从到院至抗感染给药时间:实施前5.4 h(IQR 3.5–7.7)vs 实施后4.9 h(IQR 2.5–7.1),p=0.06,未达统计学显著。
  • 从脓毒症发病至抗感染给药时间:实施前3.7 h(IQR 1.5–5.8)vs 实施后2.2 h(IQR 0.5–4.5),p<0.001。
  • 死亡率实施前18% vs 实施后16%(p=0.4)、住院率93% vs 91%(p=0.4)、急诊停留时间7.2 h vs 7.0 h(p=0.7),均无显著差异。

适用人群与场景

  • 巴黎一家学术医院急诊科的脓毒症患者,实施前(period-1)255例、实施后(period-2)180例。

诊断标准与关键阈值

  • 实施期床旁MDW随全血细胞计数由急诊护士测量、2分钟出结果,MDW高于21.5单位时要求急诊医师考虑脓毒症并尽快启动抗感染。

处置流程与药物剂量

  • 实施期(period-2):急诊护士随全血细胞计数测MDW,2分钟出结果;MDW>21.5单位时急诊医师被要求考虑脓毒症并尽快启动抗感染治疗。

研究设计与关键结果

  • 前后队列研究,纳入实施前255例与实施后180例脓毒症患者:从到院至抗感染给药时间5.4 h(IQR 3.5–7.7)vs 4.9 h(IQR 2.5–7.1),p=0.06。
  • 从脓毒症发病至抗感染给药时间由实施前3.7 h(IQR 1.5–5.8)降至实施后2.2 h(IQR 0.5–4.5),p<0.001。
  • 死亡率实施前18% vs 实施后16%(p=0.4),住院率93% vs 91%(p=0.4),急诊停留时间7.2 h(IQR 5.3–9.8)vs 7.0 h(IQR 5.4–9.4)(p=0.7)。

证据类型、等级与局限

  • 证据类型:前后队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在急诊流程中实施床旁MDW检测(MDW>21.5单位时要求急诊医师考虑脓毒症并尽快启动抗感染)可缩短从脓毒症发病至抗感染给药时间,作者认为这符合当前脓毒症管理指南。
  • 从到院至抗感染给药时间未显著缩短(5.4 h vs 4.9 h,p=0.06),死亡率、住院率与急诊停留时间无显著差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Timely recognition of sepsis in emergency department (ED) is challenging. We evaluated the impact of implementing the biomarker monocyte distribution width (MDW) at bedside, on the time to anti-infective administration.

METHODS: We conducted a before-and-after cohort study in the ED of an academic hospital in Paris, to compare sepsis patients care and outcomes, before and after the implementation of point of care (POC) MDW measurement in the ED. During post-implementation period (period-2), MDW was measured with complete blood count by ED nurses with results given in 2 min: if above 21.5 units, ED physicians were asked to consider sepsis and to start an anti-infectious as soon as possible. Primary endpoint was time to anti-infectious administration (TTA) from ED arrival, and secondary endpoints were TTA from sepsis onset (TTAS), length of stay, mortality, and hospitalization rates.

RESULTS: In total, 255 patients (period-1) and 180 patients (period-2) with sepsis were included. The TTA was 5.4 h (3.5-7.7) period-1 and 4.9 h (IQR 2.5-7.1) in period-2 (p = 0.06). MDW implementation significantly reduced the median TTAS from to 3.7 h (IQR 1.5-5.8) in period-1, to 2.2 h (IQR 0.5-4.5) in period-2 (p < 0.001). Mortality rates remained similar between the two periods (18% vs. 16% respectively, p = 0.4), as did hospitalization rates (93% vs. 91%, p = 0.4) and ED length of stay (7.2 h (5.3-9.8) vs 7.0 (5.4-9.4), p = 0.7).

CONCLUSION: Implementing POC MDW measurement in the ED protocols enhances the timeliness of anti-infective administration from sepsis onset, meeting current sepsis management guidelines.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Cancella de Abreu M, Sala T, Houas E, et al. Clinical impact of the implementation of monocyte distribution width (MDW) measurement on time to anti-infective administration in sepsis patients in the emergency department: a before/after cohort study. Crit Care. 2024. PMID: 39465419. doi:10.1186/s13054-024-05141-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。